With smartphones millions of times more powerful than the NASA Apollo computers that sent us to the moon in the 1960s, scientists have been eager to adapt them back here on Earth to better the planet.Continue reading→

Two patents have been awarded to the UA based on the novel approach of ProNeurogen to treating diseases causing memory loss and cognitive impairment.Continue reading→

The US Food and Drug Administration has awarded the Institute for Advanced Clinical Trials for Children (I-ACT for Children) a grant to improve clinical trials of new drugs and devices for children. The award establishes an alliance among I-ACT for Children and PEDSnet, the James M. Anderson Center for Health Systems Excellence, Critical Path Institute and the National Capital Consortium for Pediatric Device Innovation, to work together with leading children’s institutions and health systems to address key gaps and challenges in pediatric clinical trials.Continue reading→

What if you could experience full health until the very end of your life? UA researchers, led by Dr. Janko Nikolich-Zugich, think long-lasting immunity from disease might be possible — if the thymus and the T-cells it produces to fight infection can be brought back to work efficiently.Continue reading→

U.S. Centers for Disease Control announces creation of pilot projects geared to protect public healthContinue reading→

Administration of residency and fellowships programs will shift to UA College of Medicine – Phoenix from Banner HealthContinue reading→

Challenges in innovation are universal in many ways. The need for user requirements identification, brainstorming/ idea generation, prototype creation, and feedback collection are staples of the design process across many industries. However, a dichotomy exists for large and small companies with respect to the challenges they face when trying to create a robust product innovation process. Continue reading→

TUCSON, Ariz., and AUSTIN, Texas – October 18, 2017 –Critical Path Institute (C-Path) and The Clinical Data Interchange Standards Consortium (CDISC) announce the open availability of a Duchenne Muscular Dystrophy Therapeutic Area User Guide (TAUG-DMD v1.0), which describes the most common clinical concepts relevant to Duchenne studies using the CDISC standard format. This format allows datasets from different sources to be compared or combined for data collection, sharing, and analyses.Continue reading→

Use of arsenic trioxide could extend survival of some glioblastoma patients by three to four times historic medianContinue reading→